# Sandoz to build $400M biologics plant in Lendava, Slovenia

Sandoz committed approximately $400 million to construct a new biologics plant in Lendava, Slovenia, for manufacturing biosimilars. Construction is expected to start later in 2023, with the site becoming fully operational in 2026, adding around 300 jobs.

- Type: New facility
- Announced: 2023-03-09
- Where: Lendava, Slovenia
- Value: $400.0M
- Jobs: 300
- Starts operating: 2026
- Status: announced
- Products: biosimilars
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Sandoz](https://endata.com/companies/55313.md)

## Sources

- [endpoints.news](https://endpoints.news/sandoz-to-expand-its-presence-in-slovenia-with-new-400m-plant/), 2023-03-09: "This investment underscores our ambition to be the sustainable global leader in biosimilars, a segment projected to grow double-digit annually over the next decade."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.